{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:24:43Z","timestamp":1794349483773,"version":"4.9.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.eclinm.2025.103603","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:11:58Z","timestamp":1761855118000},"page":"103603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of HIV and hospitalization on the incidence of subsequent rifampicin-resistant tuberculosis after initiation of first-line tuberculosis treatment: a retrospective cohort study in South Africa"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6795-2450","authenticated-orcid":false,"given":"N.","family":"Zinyakatira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Boulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Tiffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.F.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2025.103603_bib1","series-title":"Global Tuberculosis Report 2024","year":"2024"},{"key":"10.1016\/j.eclinm.2025.103603_bib2","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(15)00458-0","article-title":"Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis","volume":"3","author":"Kendall","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.eclinm.2025.103603_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139017","article-title":"Risk factors for acquired rifamycin and isoniazid resistance: a systematic review and meta-analysis","volume":"10","author":"Rockwood","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2025.103603_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jinf.2018.10.004","article-title":"Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis","volume":"77","author":"Pradipta","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.eclinm.2025.103603_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/cid\/cis353","article-title":"Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy","volume":"55","author":"Pasipanodya","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2025.103603_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082235","article-title":"Association between HIV\/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis","volume":"9","author":"Mesfin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2025.103603_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1186\/s12879-024-09514-7","article-title":"Association between HIV and acquisition of rifamycin resistance with first-line TB treatment: a systematic review and meta-analysis","volume":"24","author":"Zinyakatira","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.eclinm.2025.103603_bib8","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.5588\/ijtld.15.0327","article-title":"Nosocomial transmission of multidrug-resistant tuberculosis","volume":"19","author":"Crudu","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.eclinm.2025.103603_bib9","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/cid\/ciu674","article-title":"Acquired rifampicin resistance in thrice-weekly antituberculosis therapy: impact of HIV and antiretroviral therapy","volume":"59","author":"Narendran","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2025.103603_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/380795","article-title":"Malabsorption of rifampin and isoniazid in HIV-Infected patients with and without tuberculosis","volume":"38","author":"Gurumurthy","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2025.103603_bib11","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1183\/09031936.00203613","article-title":"High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova","volume":"43","author":"Jenkins","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.eclinm.2025.103603_bib12","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/cid\/ciz491","article-title":"Rifampin-resistant tuberculosis in the United States, 1998-2014","volume":"70","author":"Sharling","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2025.103603_bib13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1473-3099(17)30247-5","article-title":"Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study","volume":"17","author":"Sharma","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eclinm.2025.103603_bib14","doi-asserted-by":"crossref","first-page":"e584","DOI":"10.1016\/S2666-5247(21)00144-0","article-title":"Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study","volume":"2","author":"Cox","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.eclinm.2025.103603_bib15","article-title":"Data centre profile: the provincial health data centre of the Western Cape Province, South Africa","volume":"4","author":"Boulle","year":"2019","journal-title":"Int J Popul Data Sci"},{"key":"10.1016\/j.eclinm.2025.103603_bib16","series-title":"Who Consolidated Guidelines on Tuberculosis: Module 4: Treatment: Drug-Susceptible Tuberculosis Treatment","year":"2022"},{"key":"10.1016\/j.eclinm.2025.103603_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0028-2023","article-title":"Treatment-shortening regimens for tuberculosis: updates and future priorities","volume":"19","author":"Saluzzo","year":"2023","journal-title":"Breathe"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103603_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018327","article-title":"Spontaneous emergence of multiple drug resistance in tuberculosis before and during therapy","volume":"6","author":"Colijn","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2025.103603_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.954074","article-title":"Evolution of Mycobacterium tuberculosis drug resistance in the genomic era","volume":"12","author":"Nimmo","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.eclinm.2025.103603_bib20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40262-018-0716-8","article-title":"A systematic review on the effect of HIV infection on the pharmacokinetics of first-line tuberculosis drugs","volume":"58","author":"Daskapan","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.eclinm.2025.103603_bib21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/infdis\/jit352","article-title":"Serum drug concentrations predictive of pulmonary tuberculosis outcomes","volume":"208","author":"Pasipanodya","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eclinm.2025.103603_bib22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/infdis\/jiw313","article-title":"Relationship between HIV coinfection, interleukin 10 production, and Mycobacterium tuberculosis in human lymph node granulomas","volume":"214","author":"Diedrich","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eclinm.2025.103603_bib23","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1093\/jac\/dkab258","article-title":"Effect of efavirenz-based ART on the pharmacokinetics of rifampicin and its primary metabolite in patients coinfected with TB and HIV","volume":"76","author":"Sundell","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eclinm.2025.103603_bib24","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1128\/AAC.05526-11","article-title":"Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines","volume":"56","author":"McIlleron","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eclinm.2025.103603_bib25","author":"Ismail"},{"key":"10.1016\/j.eclinm.2025.103603_bib26","author":"Iqbal"},{"key":"10.1016\/j.eclinm.2025.103603_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-013376","article-title":"A model-based approach to estimating the prevalence of disease combinations in South Africa","author":"Johnson","year":"2024","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.eclinm.2025.103603_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00782-20","article-title":"HIV coinfection is associated with low-fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis","volume":"64","author":"Loiseau","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eclinm.2025.103603_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jinf.2022.05.012","article-title":"Comprehensive genomic analysis of Mycobacterium tuberculosis reveals limited impact of high-fitness genotypes on MDR-TB transmission","volume":"85","author":"Chen","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.eclinm.2025.103603_bib30","author":"Boake"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025005371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025005371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:37:50Z","timestamp":1794346670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025005371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"alternative-id":["S2589537025005371"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103603","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of HIV and hospitalization on the incidence of subsequent rifampicin-resistant tuberculosis after initiation of first-line tuberculosis treatment: a retrospective cohort study in South Africa","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103603"}}